Home » Services » Clinical trials » Clinical trial services » Phase 1-4 and marketing studies
Clinical trial services related to eye diseases

Iris Pharma carries out eye clinical research trials and studies (phase 1, phase 2, phase 3 and phase 4) and medico marketing studies throughout Western and Eastern Europe, North Africa, India and North America.



Learn more about our clinical capabilities:


The clinical trial services offered by Iris Pharma for clinical trials and clinical development include strategic trial planning, regulatory requirements, medical writing and clinical operations:


Strategy and advice for eye clinical research trials

Regulatory requirements

Medical writing: expertise in eye diseases

  • Writing protocols and study summaries
  • Writing investigator´ brochures
  • Review of the Investigational Medicinal Product Dossier (IMPD)
  • Design of Case Report Forms (CRFs) and transcription to electronic Case Report Forms (eCRFs) if required
  • Design of patient diaries
  • Clinical study reports
  • Publications
  • Others medical writing

Clinical operations